Northeastern hosted the first International Translational Nanomedicine Conference over the weekend, welcoming researchers and industry experts from around the globe.
Pharmacy graduate Nick O’Donnell earned an award at the RISE:2013 expo this spring for his work investigating the adverse effects of intravenous sedatives.
Leaders of flourishing healthcare companies shared their success stories on Thursday evening at an annual event hosted by the Health Sciences Entrepreneurs, an alumni group dedicated to fostering entrepreneurship in the healthcare field.
Pharmaceutical sciences professor Barbara Waszczak and graduate student Brendan Harmon devised an intranasal gene therapy that targets the underlying cause of Parkinson’s disease, not just its symptoms.
The Bouvé College of Health Sciences supports a collaborative approach to healthcare and research, as demonstrated at the 6th annual Interprofessional Research Symposium last week.
Professor Gary Young and his colleagues at Northeastern are the first in the nation to analyze hospitals’ community benefits practices, which are intimately linked with their tax-exempt status.
In a new paper, Distinguished Professor Mansoor Amiji and his collaborators present a drug-delivery system they believe can specifically target only tumors and turn off the cancer cells’ “superpowers” that allow them to grow uncontrollably.
New research from pharmaceutical sciences professor Richard Deth suggests a regulatory role for a well-known enzyme, and it may be impaired in autism.
Senate members on Wednesday engaged in a lively discussion, the latest in a university-wide effort to gather feedback about a potential smoke-free policy.
Vladimir Torchilin, Distinguished Professor of pharmaceutical sciences, has earned a lifetime achievement award for his outstanding contributions to the field of targeted drug delivery.
Mark Douglass, an associate clinical professor of pharmacy, discusses how to protect against the flu—which is experiencing its worst outbreak in a decade—and the importance of getting a flu vaccine.
In 2009, Northeastern University network scientist Alessandro Vespignani developed a computational model that predicted the spread of the H1N1 virus. Three years later, new studies show that these predictions were highly accurate.